Oral Medications Retatrutide, as a GLP-1 and GIP receptor agonist, can delay gastric emptying
These medications can cause muscle loss alongside fat loss
Morris, MD, MBA posted thisAfter much reflection, Im stepping down as Chief Medical Officer of Ambience Healthcare
In addition to gastroparesis and stomach paralysis claims, attorneys are now investigating GLP-1 lawsuits involving permanent vision loss , including a serious eye condition known as Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
They work in three key ways to turn down the volume: They Act on the Brain: GLP-1s directly target the satiety centers in the brain, including the hypothalamus
Case Report The patient, a 4-month-old boy, presented with an expansile extra-axial lesion in the frontal midline of the skull